Caricide — Competitive Intelligence Brief

Caricide (DIETHYLCARBAMAZINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anthelmintic. Area: Infectious Disease.

marketed Anthelmintic Arachidonate 5-lipoxygenase Infectious Disease Small molecule

Target snapshot

Caricide (DIETHYLCARBAMAZINE) — Pfizer.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Caricide TARGET	DIETHYLCARBAMAZINE	Pfizer	marketed	Anthelmintic	Arachidonate 5-lipoxygenase	1950-01-01
Indion	PHENINDIONE	Sanofi	marketed	phenindione	Prothrombin, Vitamin K epoxide reductase complex subunit 1, Arachidonate 5-lipoxygenase	1982-01-01
Oraflex	BENOXAPROFEN		marketed	benoxaprofen	Arachidonate 5-lipoxygenase	1982-01-01
Andion	ANISINDIONE	Merck & Co.	marketed	anisindione	Vitamin K-dependent gamma-carboxylase, Arachidonate 5-lipoxygenase	1957-01-01
Bioxeda	Eugenol	HITEC-Institute of Medical Sciences	marketed	Standardized Chemical Allergen	Arachidonate 5-lipoxygenase, Prostaglandin G/H synthase 1
TEPOXALIN	TEPOXALIN		marketed		Prostaglandin G/H synthase 2, Arachidonate 5-lipoxygenase, Prostaglandin G/H synthase 1
Ascaricid	hexylresorcinol		marketed	hexylresorcinol	Arachidonate 5-lipoxygenase, Tyrosinase, Polyphenol oxidase 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anthelmintic class)

1. · 2 drugs in this class
2. Swiss Tropical & Public Health Institute · 2 drugs in this class
3. Merck KGaA, Darmstadt, Germany · 1 drug in this class
4. Pfizer · 1 drug in this class